Disorders due to use of multiple specified psychoactive substances, including medications

Description

Disorders due to use of multiple specified psychoactive substances, including medications are characterised by the pattern and consequences of multiple psychoactive substances. Although this grouping is provided for coding purposes, in most clinical situations it is recommended that multiple specific disorders due to substance use be assigned rather than using categories from this grouping.

Exclusions from above levels

QE62 – Uncomplicated bereavement
QE84 – Acute stress reaction

Child codes

6C4F.0 – Episode of harmful use of multiple specified psychoactive substances
6C4F.1 – Harmful pattern of use of multiple specified psychoactive substances
6C4F.2 – Multiple specified psychoactive substances dependence
6C4F.3 – Intoxication due to multiple specified psychoactive substances
6C4F.4 – Multiple specified psychoactive substances withdrawal
6C4F.5 – Delirium induced by multiple specified psychoactive substances including medications
6C4F.6 – Psychotic disorder induced by multiple specified psychoactive substances
6C4F.7 – Certain multiple specified psychoactive substances-induced mental or behavioural disorders
6C4F.Y – Other specified disorders due to use of multiple specified psychoactive substances, including medications
6C4F.Z – Disorders due to use of multiple specified psychoactive substances, including medications, unspecified

Sibling codes

6C40 – Disorders due to use of alcohol
6C41 – Disorders due to use of cannabis
6C42 – Disorders due to use of synthetic cannabinoids
6C43 – Disorders due to use of opioids
6C44 – Disorders due to use of sedatives, hypnotics or anxiolytics
6C45 – Disorders due to use of cocaine
6C46 – Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone
6C47 – Disorders due to use of synthetic cathinones
6C48 – Disorders due to use of caffeine
6C49 – Disorders due to use of hallucinogens
6C4A – Disorders due to use of nicotine
6C4B – Disorders due to use of volatile inhalants
6C4C – Disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA]
6C4D – Disorders due to use of dissociative drugs including ketamine or phencyclidine (PCP)
6C4E – Disorders due to use of other specified psychoactive substances, including medications
6C4G – Disorders due to use of unknown or unspecified psychoactive substances
6C4H – Disorders due to use of non-psychoactive substances
6C4Y – Other specified disorders due to substance use
6C4Z – Disorders due to substance use, unspecified

Foundation entity

Disorders due to use of multiple specified psychoactive substances, including medications – http://id.who.int/icd/entity/601226803

Allowed postcoordination axes

Part of: 06: Mental, behavioural or neurodevelopmental disorders